New Mexico Oncology/Hematology

Albuquerque, New Mexico 87109

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Colonic Neoplasms, Colorectal Neoplasms, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Lymphoma, Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Small Cleaved-Cell, Follicular, Metastatic Cancer

Studies at this site

• A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW). — Running, not enrolling
• BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma — Stopped early
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma — Status unconfirmed
• Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases — Completed
• Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer — Completed